Risk factors predisposing to stroke recurrence within one year of non-cardioembolic stroke onset: The Fukuoka Stroke Registry

Cerebrovascular Diseases

Volumn 33, Issue 2, 2012, Pages 141-149

  Kuwashiro, Takahiro ^a   Sugimori, Hiroshi ^a   Ago, Tetsuro ^a   Kamouchi, Masahiro ^a   Kitazono, Takanari ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Age; Chronic kidney disease; High density lipoprotein cholesterol; Non cardioembolic stroke; Recurrence

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ARTICLE; BRAIN ISCHEMIA; CHRONIC KIDNEY DISEASE; DISEASE PREDISPOSITION; DISEASE REGISTRY; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR;

AGE FACTORS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHOLESTEROL, HDL; CHRONIC DISEASE; DISEASE-FREE SURVIVAL; DOWN-REGULATION; FEMALE; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; KIDNEY DISEASES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECURRENCE; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; STROKE; TIME FACTORS;

EID: 83455258212     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000334190     Document Type: Article

References (43)

1. Dhamoon MS, Sciacca RR, Rundek T, Sacco RL, Elkind MS: Recurrent stroke and cardiac risks after first ischemic stroke: The Northern Manhattan Study. Neurology 2006; 66: 641-646. (Pubitemid 43739815)
2. Azarpazhooh MR, Nicol MB, Donnan GA, Dewey HM, Sturm JW, MacDonell RA, Pearce DC, Thrift AG: Patterns of stroke recurrence according to subtype of first stroke event: The North East Melbourne Stroke Incidence Study (NEMESIS). Int J Stroke 2008; 3: 158-164.
3. Hankey GJ, Jamrozik K, Broadhurst RJ, Forbes S, Burvill PW, Anderson CS, Stewart- Wynne EG: Long-term risk of first recurrent stroke in the Perth Community Stroke Study. Stroke 1998; 29: 2491-2500. (Pubitemid 28543996)
4. Hillen T, Coshall C, Tilling K, Rudd AG, Mc- Govern R, Wolfe CD; South London Stroke Register: Cause of stroke recurrence is multifactorial: patterns, risk factors, and outcomes of stroke recurrence in the South London Stroke Register. Stroke 2003; 34: 1457-1463. (Pubitemid 36693517)
5. Hankey GJ: Long-term outcome after ischaemic stroke/transient ischaemic attack. Cerebrovasc Dis 2003; 16(suppl 1);14-19. (Pubitemid 36438779)
6. Elkind MS: Outcomes after stroke: risk of recurrent ischemic stroke and other events. Am J Med 2009; 122:S7-S13.
7. Appelros P, Nydevik I, Viitanen M: Poor outcome after first-ever stroke: predictors for death, dependency, and recurrent stroke within the first year. Stroke 2003; 34: 122-126. (Pubitemid 36070812)
8. Xu G, Liu X, Wu W, Zhang R, Yin Q: Recurrence after ischemic stroke in Chinese patients: impact of uncontrolled modifiable risk factors. Cerebrovasc Dis 2007; 23: 117-120. (Pubitemid 46239150)
9. Toyoda K, Okada Y, Kobayashi S: Early recurrence of ischemic stroke in Japanese patients: the Japan standard stroke registry study. Cerebrovasc Dis 2007; 24: 289-295. (Pubitemid 47295599)
10. Egido JA: Benefits of modifying the predictive factors of stroke recurrence. Cerebrovasc Dis 2005; 20(suppl 2):84-90.
11. Lovett JK, Coull AJ, Rothwell PM: Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology 2004; 62: 569-573. (Pubitemid 38252797)
12. Imamura T, Doi Y, Arima H, Yonemoto K, Hata J, Kubo M, Tanizaki Y, Ibayashi S, Iida M, Kiyohara Y: LDL cholesterol and the development of stroke subtypes and coronary heart disease in a general Japanese population: the Hisayama study. Stroke 2009; 40: 382-388.
13. Kuwashiro T, Sugimori H, Kamouchi M, Ago T, Kitazono T, Iida M: Lower levels of HDL cholesterol on admission and a recurrence of ischemic stroke: a 12-month followup of the Fukuoka Stroke Registry. J Stroke Cerebrovasc Dis (in press).
14. Alvarez-Perez FJ, Castelo-Branco M, Alvarez- Sabin J: Usefulness of measurement of fibrinogen, D-dimer, D-dimer/fibrinogen ratio, C reactive protein and erythrocyte sedimentation rate to assess the pathophysiology and mechanism of ischaemic stroke. J Neurol Neurosurg Psychiatry 2011; 82: 986-992.
15. Teramoto T, Sasaki J, Ueshima H, Egusa G, Kinoshita M, Shimamoto K, Daida H, Biro S, Hirobe K, Funahashi T, Yokote K, Yokode M; Japan Atherosclerosis Society (JAS) Committee for Epidemiology and Clinical Management of Atherosclerosis: Diagnostic criteria for dyslipidemia. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. J Atheroscler Thromb 2007; 14: 155-158.
16. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A; Collaborators developing the Japanese equation for estimated GFR: Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-992.
17. Adams HP Jr., Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd: Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke 1993; 24: 35-41. (Pubitemid 23014379)
18. Johnsen SH, Mathiesen EB, Fosse E, Joakimsen O, Stensland-Bugge E, Njølstad I, Arnesen E: Elevated high-density lipoprotein cholesterol levels are protective against plaque progression: a follow-up study of 1952 persons with carotid atherosclerosis the Tromsø study. Circulation 2005; 112: 498-504. (Pubitemid 41060789)
19. Wannamethee SG, Shaper AG, Ebrahim S: HDL-Cholesterol, total cholesterol, and the risk of stroke in middle-aged British men. Stroke 2000; 31: 1882-1888. (Pubitemid 30620467)
20. Leppälä JM, Virtamo J, Fogelholm R, Albanes D, Heinonen OP: Different risk factors for different stroke subtypes: association of blood pressure, cholesterol, and antioxidants. Stroke 1999; 30: 2535-2540.
21. Sacco RL, Benson RT, Kargman DE, Boden- Albala B, Tuck C, Lin IF, Cheng JF, Paik MC, Shea S, Berglund L: High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan Stroke Study. JAMA 2001; 285: 2729-2735. (Pubitemid 32525369)
22. Canouï-Poitrine F, Luc G, Bard JM, Ferrieres J, Yarnell J, Arveiler D, Morange P, Kee F, Evans A, Amouyel P, Ducimetiere P, Empana JP; PRIME Study Group: Relative contribution of lipids and apolipoproteins to incident coronary heart disease and ischemic stroke: the PRIME Study. Cerebrovasc Dis 2010; 30: 252-259.
23. Curb JD, Abbott RD, Rodriguez BL, Masaki KH, Chen R, Popper JS, Petrovitch H, Ross GW, Schatz IJ, Belleau GC, Yano K: High density lipoprotein cholesterol and the risk of stroke in elderly men: the Honolulu heart program. Am J Epidemiol 2004; 160: 150-157. (Pubitemid 38963001)
24. Tirschwell DL, Smith NL, Heckbert SR, Lemaitre RN, Longstreth WT Jr., Psaty BM: Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups. Neurology 2004; 63: 1868-1875. (Pubitemid 39532383)
25. Sanossian N, Saver JL, Navab M, Ovbiagele B: High-density lipoprotein cholesterol: an emerging target for stroke treatment. Stroke 2007; 38: 1104-1109. (Pubitemid 46568485)
26. Berliner JA, Watson AD: A role for oxidized phospholipids in atherosclerosis. N Engl J Med 2005; 353: 9-11. (Pubitemid 41007802)
27. Navab M, Hama SY, Hough GP, Subbanagounder G, Reddy ST, Fogelman AM: A cellfree assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids. J Lipid Res 2001; 42: 1308-1317. (Pubitemid 32744255)
28. Shah PK, Kaul S, Nilsson J, Cercek B: Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming. I. Circulation 2001; 104: 2376-2383. (Pubitemid 33049524)
29. Viñals M, Martínez-González J, Badimon JJ, Badimon L: HDL-induced prostacyclin release in smooth muscle cells is dependent on cyclooxygenase-2 (Cox-2). Arterioscler Thromb Vasc Biol 1997; 17: 3481-3488. (Pubitemid 28028559)
30. White HD, Simes RJ, Anderson NE, Hankey GJ, Watson JD, Hunt D, Colquhoun DM, Glasziou P, MacMahon S, Kirby AC, West MJ, Tonkin AM: Pravastatin therapy and the risk of stroke. N Engl J Med 2000; 343: 317-326. (Pubitemid 30616697)
31. Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, Elam MB, Faas FH, Linares E, Schaefer EJ, Schectman G, Wilt TJ, Wittes J: Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans affairs high-density lipoprotein cholesterol intervention trial study group. N Engl J Med 1999; 341: 410-418. (Pubitemid 29362514)
32. Nakaya N, Kita T, Mabuchi H, Matsuzaki M, Matsuzawa Y, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H; J-LIT Study Group: Large-scale cohort study on the relationship between serum lipid concentrations and risk of cerebrovascular disease under low-dose simvastatin in Japanese patients with hypercholesterolemia: sub-analysis of the Japan Lipid Intervention Trial (J-LIT). Circ J 2005; 69: 1016-1021. (Pubitemid 41603084)
33. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, Johnston SC, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Schwamm LH, Tomsick T; American Heart Association; American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology: Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: cosponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 2006; 37: 577-617.
34. Bloomfield Rubins H, Davenport J, Babikian V, Brass LM, Collins D, Wexler L, Wagner S, Papademetriou V, Rutan G, Robins SJ; VA-HIT Study Group: Reduction in stroke with gemfibrozil in men with coronary heart disease and low HDL cholesterol: The Veterans Affairs HDL Intervention Trial (VAHIT). Circulation 2001; 103: 2828-2833. (Pubitemid 32550072)
35. Ninomiya T, Kiyohara Y, Kubo M, Tanizaki Y, Doi Y, Okubo K, Wakugawa Y, Hata J, Oishi Y, Shikata K, Yonemoto K, Hirakata H, Iida M: Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study. Kidney Int 2005; 68: 228-236. (Pubitemid 43181380)
36. Koren-Morag N, Goldbourt U, Tanne D: Renal dysfunction and risk of ischemic stroke or TIA in patients with cardiovascular disease. Neurology 2006; 67: 224-228. (Pubitemid 44305403)
37. Ovbiagele B: Impairment in glomerular filtration rate or glomerular filtration barrier and occurrence of stroke. Arch Neurol 2008; 65: 934-938. (Pubitemid 352008478)
38. Otani H, Kikuya M, Hara A, Terata S, Ohkubo T, Kondo T, Hirose T, Obara T, Metoki H, Inoue R, Asayama K, Kanno A, Terawaki H, Nakayama M, Totsune K, Hoshi H, Satoh H, Izumi S, Imai Y: Association of kidney dysfunction with silent lacunar infarcts and white matter hyperintensity in the general population: the Ohasama study. Cerebrovasc Dis 2010; 30: 43-50.
39. Naganuma M, Koga M, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Nishiyama K, Minematsu K, Toyoda K: Reduced estimated glomerular filtration rate is associated with stroke outcome after intravenous rt-PA: the Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA registry. Cerebrovasc Dis 2011; 31: 123-129.
40. Uhlig K, Levey AS, Sarnak MJ: Traditional cardiac risk factors in individuals with chronic kidney disease. Semin Dial 2003; 16: 118-127. (Pubitemid 37356824)
41. Madore F: Uremia-related metabolic cardiac risk factors in chronic kidney disease. Semin Dial 2003; 16: 148-156. (Pubitemid 37356827)
42. Seliger SL, Gillen DL, Longstreth WT Jr., Kestenbaum B, Stehman-Breen CO: Elevated risk of stroke among patients with end-stage renal disease. Kidney Int 2003; 64: 603-609. (Pubitemid 36871932)
43. Yahalom G, Schwartz R, Schwammenthal Y, Merzeliak O, Toashi M, Orion D, Sela BA, Tanne D: Chronic kidney disease and clinical outcome in patients with acute stroke. Stroke 2009; 40: 1296-1303.